← Back to all signals
RESEARCH PAPER ANALYSIS

Revisiting the Association of Preoperative Steroids, Severe Neutropenia, and Prophylactic Antibiotics on Pediatric Port Infections.

In a retrospective cohort of 1,566 pediatric port placements, severe preoperative neutropenia and steroid use were associated with higher 30-day port-infection odds, while the neutropenia association was not significant among patients receiving prophylactic antibiotics.

Open original publication →
PMID42586411
JournalJournal of pediatric surgery
Publication Date2026-08-12
Ingested2026-08-17 12:23 AM
EXECUTIVE SUMMARY

What the AI sees

In a retrospective cohort of 1,566 pediatric port placements, severe preoperative neutropenia and steroid use were associated with higher 30-day port-infection odds, while the neutropenia association was not significant among patients receiving prophylactic antibiotics.

WHY IT MATTERS

Research significance

The evidence supports associations rather than causation; it raises the hypothesis that targeted perioperative antibiotic prophylaxis or delaying port placement during severe neutropenia could reduce early port infections, but prospective studies are needed before either strategy can be considered established.

ABSTRACT

Source abstract

PURPOSE: The impact of preoperative absolute neutrophil count (ANC), steroids, and prophylactic antibiotics on port infection risk remains controversial. As infections represent a significant complication of pediatric port placement, we sought to identify specific risk factors associated with port infection at our institution. METHODS: Ports placed from 2013-2024 at our children's hospital were retrospectively reviewed. Exclusion criteria was absence of 72-hour preoperative ANC data. Severe neutropenia was defined as ANC<500 cells/mm3. Multivariable logistic regression identified risk factors associated with port infection and removal within 30 days of placement. RESULTS: Of 1566 ports meeting inclusion criteria, indications were liquid malignancy (44.3%), solid tumors (42.2%), and benign diagnoses (13.5%); 16.4% were placed in context of severe neutropenia. The overall 30-day port infection rate was 5.6%. Of infected ports, 31.0% required removal. Children with severe neutropenia were significantly more likely to develop port-associated infections (aOR 1.832 [1.010-3.325], p=0.0464). This risk persisted in those who did not receive prophylactic antibiotics (aOR 2.126 [1.064-4.249], p=0.0328) but became non-significant in the subgroup receiving antibiotic prophylaxis (p=0.7866). Steroid use was associated with increased odds of port infection (aOR 1.705 [1.064-2.734], p=0.0266) and removal (aOR 3.592 [1.570-8.216], p=0.0025). CONCLUSIONS: In a large-scale cohort of pediatric port placement, steroids and severe neutropenia increased the odds of port infection while prophylactic antibiotics helped mitigate this risk. These findings demonstrate a potential protective benefit of prophylactic antibiotic use and support consideration of delayed port placement in severely neutropenic children. Prospective studies are warranted to clarify these relationships and inform clinical standard practice recommendations in children.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Biomarker-Negative and MIBG-Negative Neuroblastoma Presenting as an Indeterminate Retroperitoneal Mass in a Young Child. Pediatrics international : official journal of the Japan Pediatric Society 29.85 2 Hypophosphatemic rickets in children: current knowledge and a proposal for a diagnostic algorithm. Endokrynologia Polska 58.0 3 Effectiveness of the "Golden Hour" program in preventing sepsis in pediatric patients with acute lymphoblastic leukemia. Boletin medico del Hospital Infantil de Mexico 65.0 4 Clinical validation of the nursing diagnosis of inadequate nutritional intake in children with cancer. International journal of nursing knowledge 67.6 5 Exploratory Analysis of the Inhibitory Effects of Propranolol on NLRP3 and Pyrin Inflammasomes. ACR open rheumatology 56.76 6 First-In-Human Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of Tilpisertib Fosmecarbil (GS-5290), an Oral Prodrug of a Tumor Progression Locus 2 Inhibitor in Healthy Participants. Journal of clinical pharmacology 84.72 7 Dyadic Latent Profiles of Sexual and Reproductive Distress in Young Adult Cancer Survivors and Their Partners: A Cross-Sectional Analysis. Psycho-oncology 61.0 8 Disproportionality analysis of drug-induced myocarditis: Insights from the Food and Drug Administration Adverse Event Reporting System database. The Journal of international medical research 63.68 9 Innovative Insights into Osteosarcoma: Unraveling the Role of LncRNAs, miRNAs, and CircRNAs in Tumorigenesis and Therapeutic Resistance. Current gene therapy 63.84 10 Targeting Metal-Dependent Cell Death in Cancer: From Molecular Circuitry to Biomarker-Guided Precision Combination Therapy. Current cancer drug targets 70.99 11 Long-term outcomes of non-operative compared to operative management of acute uncomplicated appendicitis - a systematic review and meta-analysis. American journal of surgery 72.5 12 What have I missed again: A qualitative study exploring parents of children with cancer's experiences of fear of missing out. Journal of health psychology 54.0 13 Radiographic overestimation of inferior vena cava involvement in pediatric neuroblastoma: a case report. Journal of surgical case reports 55.5 14 Global Burden and Temporal Trends of Brain and Central Nervous System Tumors in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 2021. Cancer innovation 56.0 15 Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report. The American journal of case reports 53.92 16 Modern management and multidisciplinary care of bladder prostate rhabdomyosarcoma. Current opinion in pediatrics 62.8 17 Improving Dietary Data Quality in Nutrition Studies: Development and Validation of an Explainable, Reproducible, Open Machine Learning-Assisted Framework for Outlier Detection in 24-Hour Recalls. American journal of epidemiology 61.5 18 Genetic Markers of Early Skeletal Muscle Loss in Adolescent and Young Adult Cancer Patients Treated with Anthracyclines. Journal of adolescent and young adult oncology 65.5 19 Seen, Heard, and Still Missing: Understanding Clinical Trial Nonparticipation Among Women of Color. Journal of adolescent and young adult oncology 74.5 20 Correction to "Health-Related Quality of Life in Chinese Children and Adolescents With Cancer: A Systematic Review and Meta-Analysis". International journal of cancer 63.0 21 Evolution of robotic-assisted resection of pediatric neuroblastic tumors: a retrospective analysis. Updates in surgery 61.5 22 Late cardiac effects of anthracycline-based therapy in childhood cancer survivors: a CMR study of cardiac strain and function. Clinical research in cardiology : official journal of the German Cardiac Society 68.34 23 Biological reconstruction in the growing child after tumour resection: long-term outcomes of vascularized fibular epiphyseal transfer. International orthopaedics 57.2 24 Neuroimaging findings of the hypothalamus and pituitary gland in children with growth hormone deficiency: a 25-year single-center retrospective study. Hormones (Athens, Greece) 67.0 25 Ovarian Lymphoma and Bone Metastasis Presenting With Paraparesis in an Adolescent: A Case Report. The American journal of case reports 51.9 26 Evaluating the impact of virtual oncology financial and legal navigation on cancer-related financial toxicity. JNCI cancer spectrum 63.12 27 Pharmacogenetic variants in the molecular characterization initiative: a report from the children's oncology group. Journal of the National Cancer Institute 65.4 28 Impact of Satisfactory Family Coping on the Mental Health of Parents Whose Children Died of Cancer. Journal of pain and symptom management 59.5 29 Surgical approach to solid breast masses in girls. Journal of pediatric and adolescent gynecology 58.4 30 Pediatric and Adolescent Gynecological Tumors and Associated Predisposition Syndromes. Journal of pediatric and adolescent gynecology 56.0 31 Facial nerve schwannoma of the accessory parotid gland region in a child managed through a transoral approach. BMJ case reports 56.0 32 Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study. The Lancet. Oncology 85.2
PATIENT-FRIENDLY SUMMARY

Revisiting the Association of Preoperative Steroids, Severe Neutropenia, and Prophylactic Antibiotics on Pediatric Port Infections.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic